HomeFinanceFirst Pill for Postpartum Depression Is Approved by FDA Finance First Pill for Postpartum Depression Is Approved by FDA By NP August 4, 2023 0 10 Share FacebookTwitterPinterestWhatsApp The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a recent trial. Source link TagsBIIBBiogenC&E Industry News FilterContent TypescorporateCorporate/Industrial NewsdevelopmentFactiva Filtersgeneral newsgovernment policyHealthhealthcareHealthcare/Life Sciencesindustrial newslife sciencesMedical ConditionsMental DisordersMood Disordersnew productNew Product/Service Testingnew productsNew Products/ServicesPharmaceuticalspoliticalPolitical/General NewsproductProduct/Service ApprovalsproductsProducts/ServicesregulationRegulation/Government PolicyresearchResearch/DevelopmentSAGESage Therapeuticsservice approvalsservice testingservicesSYNDWSJ-PRO-WSJ.comwsjhealth Share FacebookTwitterPinterestWhatsApp Previous articleJake and Logan Paul have officially taken over combat sportsNext articleFor the First Time, There’s a Pill for Postpartum Depression NPhttps://globnews.net RELATED ARTICLES Finance I’ve been an actor for over 40 years, here’s why my next role might be my most important September 30, 2023 Finance We had almost $500K in student loan debt. Here’s how we managed to pay it off September 30, 2023 Finance Climate extremists are afraid to debate. Maybe they should be September 29, 2023 LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment. Δ Most Popular Highlights: US averts government shutdown October 1, 2023 Flames executive Snow, 42, dies after ALS battle October 1, 2023 Five new cargo vessels heading for Ukrainian Black Sea ports: MarineTraffic October 1, 2023 Sources: Raiders to start rookie O’Connell at QB October 1, 2023 Load more Recent Comments
